VIKING GLOBAL PERFORMANCE LLC Insider Trading $EDIT Editas Medicine, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for VIKING GLOBAL PERFORMANCE LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of VIKING GLOBAL PERFORMANCE LLC. VIKING GLOBAL PERFORMANCE LLC is 10% Owner in Arbutus Biopharma Corp ($TKMR) and 10% Owner in Adaptive Biotechnologies Corp ($ADPT) and 10% Owner in Axovant Sciences Ltd. ($AXON) and 10% Owner in Editas Medicine, Inc. ($EDIT) and 10% Owner in Myovant Sciences Ltd. ($MYOV) and 10% Owner in BridgeBio Pharma, Inc. ($BBIO) and 10% Owner in Urovant Sciences Ltd. ($UROV).
VIKING GLOBAL PERFORMANCE LLC in Editas Medicine, Inc.
Trading Symbol: EDITIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of VIKING GLOBAL PERFORMANCE LLC: 10% Owner
Holdings: 266,782 shares
Current Value: $4,951,474
Latest Transaction: Feb 08 2016
$EDIT Market Capitalization: $636.78M
$EDIT Previous Close: $18.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of VIKING GLOBAL PERFORMANCE LLC in Editas Medicine, Inc.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ADPT, TKMR, BBIO, EDIT, MYOV, AXON, UROV
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Option Exercise | C | 0.00 | 4,444,444 | 0 | 0 | |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 5,335 | 0 | 266,782 | 261.4 K to 266.8 K (+2.04 %) |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 261,447 | 0 | 261,447 | 0 to 261.4 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 481,567 | 0 | 481,567 | 0 to 481.6 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 15,072 | 0 | 15,072 | 0 to 15.1 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 256,986 | 0 | 256,986 | 0 to 257 K |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 20,407 | 0 | 2,729,808 | 2.7 M to 2.7 M (+0.75 %) |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | P | 0.00 | 1,000,000 | 0 | 2,709,401 | 1.7 M to 2.7 M (+58.50 %) |
Feb 08 2016 | EDIT | Editas Medicine, I ... | VIKING GLOBAL PERFORMANCE LLC | 10% Owner | Buy | C | 0.00 | 1,709,401 | 0 | 1,709,401 | 0 to 1.7 M |
Page: 1